Logo image of ADRA

ADARA ACQUISITION CORP-CL A (ADRA) Stock Fundamental Analysis

NYSEARCA:ADRA - NYSE Arca - US00653H1023 - Common Stock - Currency: USD

8.15  -1.31 (-13.82%)

Fundamental Rating

2

Taking everything into account, ADRA scores 2 out of 10 in our fundamental rating. ADRA was compared to 0 industry peers in the Unkown industry. While ADRA seems to be doing ok healthwise, there are quite some concerns on its profitability. ADRA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ADRA was profitable.
ADRA had a negative operating cash flow in the past year.
ADRA Yearly Net Income VS EBIT VS OCF VS FCFADRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 1M 2M 3M

1.2 Ratios

Industry RankSector Rank
ROA 1.58%
ROE 1.63%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADRA Yearly ROA, ROE, ROICADRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 -10 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADRA Yearly Profit, Operating, Gross MarginsADRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

ADRA has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ADRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ADRA Yearly Shares OutstandingADRA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M
ADRA Yearly Total Debt VS Total AssetsADRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

ADRA has an Altman-Z score of 20.32. This indicates that ADRA is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for ADRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.32
ROIC/WACCN/A
WACCN/A
ADRA Yearly LT Debt VS Equity VS FCFADRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.05 indicates that ADRA may have some problems paying its short term obligations.
ADRA has a Quick Ratio of 0.05. This is a bad value and indicates that ADRA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
ADRA Yearly Current Assets VS Current LiabilitesADRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 200K 400K 600K 800K

More info and screens

1

3. Growth

3.1 Past

ADRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51579.05%, which is quite impressive.
EPS 1Y (TTM)51579.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADRA Yearly Revenue VS EstimatesADRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2020 2021 200K 400K 600K
ADRA Yearly EPS VS EstimatesADRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2020 2021

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 62.69, which means the current valuation is very expensive for ADRA.
ADRA is valuated expensively when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 62.69
Fwd PE N/A
ADRA Price Earnings VS Forward Price EarningsADRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADRA Per share dataADRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ADRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADARA ACQUISITION CORP-CL A

NYSEARCA:ADRA (2/10/2023, 8:04:01 PM)

8.15

-1.31 (-13.82%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap0
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 62.69
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)0.13
EY1.6%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS7.89
TBVpS7.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.58%
ROE 1.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 20.32
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51579.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17725.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.97%
OCF growth 3YN/A
OCF growth 5YN/A